Injeq Oy (Ltd), a Finland-based MedTech company, is set to close its equity crowdfunding campaign on Invesdor with more than €1.6 million from close to 700 investors. The initiative was launched back in May and quickly secured its initial €825,000 funding target for the company’s smart Injeq IQ-Needle.
According to Injeq Oy, the smart needle products have been used in clinical patient trials and the positive performance has been reported in the Journal of Clinical Monitoring and Computing. A lumbar puncture study with pediatric patients started in 2016 and is today proceeding at two university hospitals in Tampere and Turku. Kai Kronström, CEO of Injeq Oy, previously shared:
“Many of our previous owners are physicians or dentists by profession which to us has always enforced that we are solving a real and worthwhile problem. Solving this problem also establishes a base for business and we are happy to now offer a larger crowd an opportunity to join us in the next phase of bringing the smart needle to everyday healthcare.We are now in a situation where the design has been completed and we are ready to start production very quickly and make a first market entry in children’s hospitals. We have a unique product fulfilling an unmet clinical need.”
Funds from the Invesdor campaign will reused to continue Injeq Oy’s clinical studies expansion into hospitals in Sweden, Norway, and Denmark. Commercial deliveries for the needle will take place during the first half of 2018. The campaign will close on July 4th.
Have a crowdfunding offering you'd like to share? Submit an offering for consideration using our Submit a Tip form and we may share it on our site!